2024 HCPCS Code J7626
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
TAGS: inhalation administered final through
| Short Description | Budesonide non-comp unit |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2007 |
| HCPCS Code Added Date | January 01, 2002 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J9309 - Inj, polatuzumab vedotin 1mg
- J9310 - Rituximab injection
- J9311 - Inj rituximab, hyaluronidase
- J9312 - Inj., rituximab, 10 mg
- J9313 - Inj., lumoxiti, 0.01 mg
- J9314 - Inj pemetrexed (teva) 10mg
- J9315 - Romidepsin injection
- J9316 - Pertuzu, trastuzu, 10 mg
- J9317 - Sacituzumab govitecan-hziy
- J9318 - Inj romidepsin non-lyo 0.1mg
- J9319 - Inj romidepsin lyophil 0.1mg
- J9320 - Streptozocin injection
- J9321 - Inj epcoritamab-bysp 0.16 mg
- J9322 - Inj pemetrexed (bluepoint)
- J9323 - Inj pemetrexed ditromethamin
- J9324 - Inj, pemrydi rtu, 10 mg
- J9325 - Inj talimogene laherparepvec
- J9328 - Temozolomide injection
- J9330 - Temsirolimus injection
- J9331 - Inj sirolimus prot part 1 mg